Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.61 |
| ▸ | CA2 | P00918 | 5/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.61 |
| ▸ | PARP1 | P09874 | 1/20 | 0.61 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.61 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.51 |
| ▸ | ACR | P10323 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28845837 | 0.94 | PARP10 (0.66) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL27596967 | 0.94 | KIF11 (0.59) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL3964510 | 0.88 | F3 (0.50) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL6284986 | 0.87 | KMT2A (0.64) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL28304654 | 0.84 | L3MBTL1 (0.62) | MEN1KMT2ASMN1; SMN2LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL10436132 | 0.82 | L3MBTL1 (0.60) | MEN1KMT2ASMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL28213866 | 0.82 | CA1 (0.57) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL473211 | 0.81 | LMNA (0.64) | CA1CA2PARP10CA9MEN1 | |
| SCHEMBL7061292 | 0.80 | CES2 (0.58) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL1398350 | 0.80 | CES2 (0.58) | CA1CA2PARP10PARP1PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113214339-A | Panaxadiol derivatives, preparation method and medical application thereof | 延边大学 | 2021-08-06 | — | — | CN | claimed |
| CN-108864127-B | Oxidobicycloheptene sulfonamide compound with different alkyl chain lengths as well as preparation method and application thereof | 武汉大学 | 2020-06-23 | — | — | CN | claimed |
| CN-106046100-A | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases | 拜耳知识产权有限责任公司 | 2016-10-26 | — | — | CN | claimed |
| US-20260034228-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | SDG LLC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12377154-B2 | Drug delivery system for treating disease | SDG, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2024062843-A1 | COLORED COMPOSITION, COLORED PRODUCT, AND COMPOUND | 富士フイルム株式会社 | 2024-03-28 | — | — | WO | disclosed |
| WO-2024024438-A1 | CLATHRATE COMPOUND AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | disclosed |
| WO-2024004793-A1 | COMPOUND, COMPOSITION, FILM, METHOD FOR PRODUCING COLORED COMPOSITION, AND METHOD FOR PRODUCING LAMINATE FOR DISPLAY ELEMENT | 富士フイルム株式会社 | 2024-01-04 | — | — | WO | disclosed |
| WO-2024004492-A1 | PHOTOSENSITIVE COMPOSITION, TRANSFER FILM, LAMINATE, AND METHOD FOR MANUFACTURING SAME, AND MICRO LED DISPLAY | 富士フイルム株式会社 | 2024-01-04 | — | — | WO | disclosed |
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | SDG, LLC | 2023-11-30 | — | — | US | disclosed |
| WO-2023190070-A1 | COMPOUND, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE | 富士フイルム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-0556700-A1 | Silver halide color photosensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1993-08-25 | — | — | EP | disclosed |
| EP-0545420-A2 | Imidazole azo dyes and thermal transfer dye donating materials containing them | FUJI PHOTO FILM CO., LTD. (JP) | 1993-06-09 | — | — | EP | disclosed |
| EP-0518238-A1 | Pyrrolotriazole derivative | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-16 | — | — | EP | disclosed |
| EP-0244160-B1 | LIGHT-SENSITIVE SILVER HALIDE PHOTOGRAPHIC MATERIAL IMPROVED IN STABILITY OF DYE IMAGE | KONICA CORPORATION (JP) | 1990-10-17 | — | — | EP | disclosed |
| US-4914206-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0296811-A3 | CARBAMATES OF 4-HYDROXYANISOLE AS PRODRUGS FOR CHEMOTHERAPY OF MELANOMA | MERCK & CO. INC. (US) | 1990-03-21 | — | — | EP | disclosed |
| US-4812590-A | Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma | MERCK & CO., INC. (US) | 1989-03-14 | — | — | US | disclosed |
| EP-0296811-A2 | Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma | MERCK & CO. INC. (US) | 1988-12-28 | — | — | EP | disclosed |
| EP-0226896-A2 | Lankacidin derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034228-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | HM13, HCAR2, HBZ | CA1 713/4885CA2 663/4885PARP10 2569/4885 |
| US-12377154-B2 | Drug delivery system for treating disease | HPGDS, VHL, HPSE | CA1 1007/4885CA2 636/4885PARP10 4288/4885 |
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | HPGDS, VHL, HPSE | CA1 1007/4885CA2 636/4885PARP10 4288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.